Member Info for nomlungu

The science is advancing - Big Bios will not necessarily win. As you should be aware, the NHS anonymises and shares individual patient data. The UK government is [slowly] publishing data sets that can be queried. https://www.bmj.com/content/350/bmj.h1139.full.print https://data.gov.uk/

A conspiracy theory about a hypothetical company: There is a hypothetical company that needs funding to continue to operate but the shareholders are unwilling to approve the creation and placing of more shares to resolve the funding issue. The intellectual property owned by the company is not easily valued so fund raising on the back of the IP is not currently feasible. In the meantime the hypothetical company nears running out of funding and the directors have to consider that they will imminently be trading whilst insolvent, which would make them personally liable for any debts of the company. What do they do? Will they consider a pre-pack administration? Do the directors create a company and buy the IP themselves and then force bankruptcy on the original company. They could then list the newly formed company with articles that allow the board to create as many shares as they wish in the future so they would never face the problem of asking reluctant shareholders to approve future dilutions? Until the hypothetical company updates shareholders there will always be some who consider conspiracies... As the saying goes some people would bite their own nose off to spite their face. IMO, DYOR etc.

https://www.bloomberg.com/news/articles/2018-06-07/glitch-hits-london-stock-exchange-open-on-thursday

Obelix, The report you suggest reading costs $3300 - a bit rich for most who read this board. They have another report about Valirx that is 'only' $250: https://www.htfmarketreport.com/reports/433797-valirx-plc-val-pharmaceuticals-healthcare-deals-and-alliances-profile-1 As far as I am aware these 'reports' are produced by software and are off little value. IMO DYOR etc

bassguy, Despite the website's name it is useful as it uses live data - the trades shown on this website are delayed by 15 minutes. You can change the ticker code ggp for any other lse share you are interested in. http://pumpedordumped.com/prices/price.php?latest=ggp

why do you think that?

why do you think that?

A question for the resident gurus... Do any of you have thoughts about this article? https://www.frontiersin.org/articles/10.3389/fonc.2015.00140/full or this one? https://www.frontiersin.org/research-topics/2440/emerging-role-of-misfolded-proteins-in-human-cancer The brave new world...

Links for those interested in the science: https://www.frontiersin.org/articles/10.3389/fonc.2015.00140/full https://www.nhs.uk/conditions/endometriosis/ IMO, DYOR etc

I presume you are referring to this article: https://www.bbc.co.uk/news/health-44338276 The article is about successful immunotherapy - the only relevance to VAL401 is that it may be useful alongside immunotherapy drugs or chemo. Some may find the link below interesting: https://www.frontiersin.org/research-topics/2440/emerging-role-of-misfolded-proteins-in-human-cancer IMO, DYOR etc

well said BritishBulldog.

350 percent down - you need to go back to school and learn basic maths CHELSEA7. Maybe you understand this but I do not think so [square root(minus 1) =i https://en.wikipedia.org/wiki/Imaginary_unit

interesting reading http://www.bbc.co.uk/news/health-44343415

The meanderings of Gervaise R.J. Heddle http://www.themoneyenigma.com/a-letter-from-gold-to-president-trump/ Great reading into the Chief Executive Officer's thoughts

If the BOD were so worried about abuse why would they have their photos on Valirx's website - some even have their details on the voters roll. Are you not just excusing them for the delay in keeping private investors informed. IMO, DYOR etc - do not believe what is posted on bulletin boards or assume what the motivation of the poster is.

Fredd1eboy, The impending financing requirements are not a perceived potential weakness - it is a reality. Either Valirx receive funding from an interested third party or they will need to raise funds one way or another to keep progressing towards a [hopefully] profitable future.

Why are the recent investor events not on Valirx's website?

thanks to google translate...

More potential dilution? Entralta? http://entralta.com/ More fund raising?

The Edinburgh event was for future investors but the BOD seems to have no authority to issue more shares - what is expected - to me it is a coin toss; either a big pharma pays for the trials or Valirx needs to dilute share holders?